Olmen, Belgium

Nele Vandermaesen

USPTO Granted Patents = 7 



Average Co-Inventor Count = 7.8

ph-index = 4

Forward Citations = 33(Granted Patents)


Location History:

  • Janssen Pharmaceutica N.V., Tumhoutseweg 30, Beerse, 2340, BE (2006)
  • Olmen, BE (2006 - 2011)

Company Filing History:


Years Active: 2006-2011

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Nele Vandermaesen: Innovator in Medicinal Chemistry

Introduction

Nele Vandermaesen is a prominent inventor based in Olmen, Belgium, known for her significant contributions to medicinal chemistry. With a total of seven patents to her name, she has made remarkable strides in the development of pharmaceutical compounds aimed at treating inflammatory and autoimmune diseases.

Latest Patents

Among her latest innovations are two notable patents. The first patent involves 2,4-disubstituted thiazolyl derivatives, which focuses on the use of a compound of formula (I'). The second patent pertains to 2-amino-4,5-trisubstituted thiazolyl derivatives, which also concerns the use of a compound of formula (I'). These inventions are designed for the manufacture of a medicament for the prevention or treatment of inflammatory and/or autoimmune diseases mediated through TNF-α and/or IL-12.

Career Highlights

Nele has worked with Janssen Pharmaceutica, a leading pharmaceutical company, where she has honed her skills and expertise in drug development. Her work has been instrumental in advancing the field of medicinal chemistry, particularly in the area of therapeutic agents.

Collaborations

Throughout her career, Nele has collaborated with notable professionals, including Christopher John Love and Ludwig Paul Cooymans. These partnerships have contributed to her innovative research and development efforts.

Conclusion

Nele Vandermaesen's work exemplifies the impact of innovation in the pharmaceutical industry. Her patents and collaborations highlight her commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…